Targeting the Hippo- Yes-Associated Protein/Transcriptional Coactivator with PDZ-Binding Motif Signaling Pathway in Primary Liver Cancer Therapy

Targeting the Hippo- Yes-Associated Protein/Transcriptional Coactivator with PDZ-Binding Motif Signaling Pathway in Primary Liver Cancer Therapy

Liver cancer imposes a pervasive global health challenge, ranking among the most prevalent cancers worldwide. Its prevalence and mortality rates are on a concerning upward trajectory and exacerbated by the dearth of efficacious treatment options. The Hippo signaling pathway, originally discovered in...

Full description

Bibliographic Details
Main Authors: Yina Wang, Liangyou Rui
Format: Article
Language:English
Published: MDPI AG 2024-08-01
Series:Onco
Subjects:
Hippo signaling
YAP/TAZ
liver cancer
therapy targets
Online Access:https://www.mdpi.com/2673-7523/4/3/16

Internet

https://www.mdpi.com/2673-7523/4/3/16

Similar Items